State right-to-try laws revive a decades-long debate about balancing early access to unapproved medications for terminally ill patients with requirements for demonstrated safety and effectiveness. Although the legal approach is novel, there are many reasons to believe that the laws are likely to be futile. The laws also raise questions about the roles of the state and federal governments in overseeing drugs and medical devices.
The Strange Allure of State "Right-to-Try" LawsJAMA Internal Medicine
Citation InformationPatricia J. Zettler & Henry T. Greely, The Strange Allure of State "Right-to-Try" Laws, 174 JAMA Internal Med. 1885 (2014).